{
    "title": "Pfizer's COVID antiviral Paxlovid gains full US approval",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12124559/U-S-FDA-approves-Pfizers-COVID-antiviral-pill.html",
    "date": "2023-05-25",
    "keywords": [
        "paxlovid",
        "pfizer",
        "treatment",
        "government",
        "covid",
        "approval",
        "course",
        "drug",
        "thursday",
        "covid19",
        "drugmaker",
        "market",
        "emergency",
        "fda",
        "price",
        "food",
        "administration",
        "way",
        "use",
        "authorization",
        "need",
        "agency",
        "twodrug",
        "therapy",
        "risk",
        "progression",
        "disease",
        "onset",
        "reduction",
        "benefit",
        "higherrisk",
        "inventory",
        "country",
        "spokesperson",
        "company",
        "statement",
        "time",
        "distribution",
        "charge",
        "marketing",
        "campaign",
        "institute",
        "review",
        "pricing",
        "research",
        "group",
        "december",
        "value",
        "range",
        "cash",
        "windfall",
        "vaccine",
        "year",
        "health",
        "status",
        "meeting",
        "outside",
        "safety",
        "rebound",
        "return",
        "president",
        "joe",
        "biden",
        "dr",
        "anthony",
        "fauci",
        "reporting",
        "khushi",
        "mandowara",
        "bhanvi",
        "satija",
        "bengaluru",
        "michael",
        "erman",
        "york",
        "editing",
        "kalluvila",
        "bill",
        "berkrot"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}